Health experts urge HPV vaccine for boys to prevent cancer risks
Health experts are advocating for the HPV vaccine to be given to boys aged 9 to 14 to prevent penile, anal, and oropharyngeal cancers. The vaccine is already approved for boys in India, with two doses required. Previously, the HPV vaccine was primarily recommended for girls to prevent cervical cancer. Now, experts emphasize that vaccinating boys can significantly reduce the risk of HPV-related cancers. The HPV vaccine costs around Rs 6000, while India's Cervavac is available for Rs 2000. Experts suggest including the vaccine in the Universal Immunisation Program to enhance its reach and effectiveness.